Evidence map›Paper›PMID 26241153›Full record

ArticleBehavioural pharmacology2015

Effects of oxytocin on aggressive responding in healthy adult men.

Joseph L Alcorn, Charles E Green, Joy Schmitz, Scott D Lane

Abstract read
In one paragraph

Article in Behavioural pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joseph L AlcornaDepartment of Psychiatry and Behavioral Sciences, School of Medicine bProgram in Neuroscience, Graduate School of Biomedical Sciences cCenter for Neurobehavioral Research on Addiction, University of Texas Health Science Center, Houston, Texas, USA.
Charles E Green
Joy Schmitz
Scott D Lane
Institute of Behavioral Sciences · JP

Funding

Translational MR Imaging in Cocaine Pharmacotherapy DevelopmentP50DA009262 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GREEN, CHARLES EDWARD · 1994 to 2014
$26.9M
Research Training in Drug Abuse BehaviorT32DA035200 · NIDA · UNIVERSITY OF KENTUCKY · PI CRAIG R RUSH, William Walton Stoops · 2013 to 2026
$4.4M
DRUGS OF ABUSE AND HUMAN AGGRESSIVE BEHAVIORR01DA003166 · NIDA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LANE, SCOTT D · 1985 to 2010
$2.7M
NIDA NIH HHS DA P50 09262NIDA NIH HHS DA R01 003166NIDA NIH HHS P50 DA009262NIDA NIH HHS R01 DA003166NIDA NIH HHS T32 DA035200
6 · The paper itself

Abstract

This study investigated the acute effects of oxytocin (OT) on human aggression using a well-established laboratory measure of state (reactive) aggression to test the hypothesis that OT would decrease the frequency of aggressive responding. In a within-subject design, 17 healthy male volunteers received placebo or 24 IU of intranasal OT. Aggression was measured using the Point Subtraction Aggression Paradigm at 30 min before and 30, 60, and 90 min after dose. Acute OT did not produce a significant main effect on aggressive behavior. OT attenuated the expected rise in diastolic blood pressure from morning to early afternoon observed under placebo, providing a possible indication of biological activity. Examination of individual differences showed that aggressive responding following OT dosing (but not placebo) was positively correlated with psychometric measures of interpersonal manipulation and anger (Pearson's r=0.57), indicating that higher scores on these antisocial personality traits were related to increased aggressive behavior following OT administration. These preliminary results stand in contrast to previous work on the prosocial effects of OT and highlight the need for further understanding of individual differences in aggression following OT administration. Such individual differences may have implications for the therapeutic use of OT in individuals with psychiatric disorders and dysfunctional social behavior.

Indexed as

Administration, IntranasalAdultAggressionHumansHydrocortisoneMaleMiddle AgedOxytocinSocial BehaviorHydrocortisoneOxytocin

Identifiers

PMID26241153
PMCPMC4631637
OpenAlexW1116492600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.